Literature DB >> 12621093

Chlamydia pneumoniae infection in adult patients with persistent cough.

Naoyuki Miyashita1, Hiroshi Fukano1, Koichiro Yoshida1, Yoshihito Niki1, Toshiharu Matsushima1.   

Abstract

Chlamydia pneumoniae is a frequent causative agent of acute respiratory disease. To assess whether C. pneumoniae plays a role in persistent cough, the prevalence of C. pneumoniae infection in adult patients with persistent cough was investigated. Nasopharyngeal swabs and serology samples from 366 adult patients with a persistent cough lasting in excess of 2 weeks and 106 control subjects were analysed for bacterial isolation and by PCR. C. pneumoniae was isolated from two patients and from none of the controls and was detected by PCR in 20 patients and one control. Serological evidence of acute C. pneumoniae infection was present in 24 patients but in none of the controls. Of these 20 patients who were positive by culture and/or PCR, three were still positive by PCR after 2 weeks of treatment with clarithromycin and symptoms either continued or relapsed. However, when patients were treated with clarithromycin for 5-6 weeks, their symptoms disappeared completely and the results of their cultures and/or PCR for C. pneumoniae became negative. These data suggest that C. pneumoniae infection may cause persistent cough in adults. Furthermore, these data also indicate that it may be necessary to eradicate the organism when C. pneumoniae is detected by culture and/or PCR in patients with persistent cough.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12621093     DOI: 10.1099/jmm.0.04986-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  7 in total

1.  Chlamydophila pneumoniae and Mycoplasma pneumoniae in respiratory specimens of children with chronic lung diseases.

Authors:  N Teig; A Anders; C Schmidt; C Rieger; S Gatermann
Journal:  Thorax       Date:  2005-09-02       Impact factor: 9.139

2.  Effects of repeated Chlamydia pneumoniae inoculations on aortic lipid accumulation and inflammatory response in C57BL/6J mice.

Authors:  Liisa Törmäkangas; Leena Erkkilä; Taina Korhonen; Terttu Tiirola; Aini Bloigu; Pekka Saikku; Maija Leinonen
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  Age-related differences in patterns of increased Bordetella pertussis antibodies.

Authors:  Harry E Prince; Jay M Lieberman; James D Cherry
Journal:  Clin Vaccine Immunol       Date:  2012-02-22

4.  Telithromycin treatment of chronic Chlamydia pneumoniae infection in C57BL/6J mice.

Authors:  Liisa Törmäkangas; Hannu Alakärppä; Denise Bem David; Maija Leinonen; Pekka Saikku
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

Review 5.  Curative Effects of Suhuang Zhike Capsule on Postinfectious Cough: A Meta-Analysis of Randomized Trials.

Authors:  Pinpin Ding; Qian Wang; Jing Yao; Xian-Mei Zhou; Jia Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2016-08-28       Impact factor: 2.629

6.  Pathogens Causing Upper Respiratory Tract Infections in Outpatients.

Authors:  A Jama-Kmiecik; M Frej-Mądrzak; J Sarowska; I Choroszy-Król
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

7.  Diagnostic value of symptoms and laboratory data for pertussis in adolescent and adult patients.

Authors:  Naoyuki Miyashita; Hiroto Akaike; Hideto Teranishi; Yasuhiro Kawai; Kazunobu Ouchi; Tadashi Kato; Toshikiyo Hayashi; Niro Okimoto
Journal:  BMC Infect Dis       Date:  2013-03-11       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.